ABAmanda Bellanti

Amanda Bellanti

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amanda Bellanti has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Anastasia Pavlidou

    Translational Research Center, University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland

    3 shared publications
  • Andreas Meyer-Lindenberg

    Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany

    3 shared publications
  • Dusan Hirjak

    Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany

    3 shared publications
  • Geva A. Brandt

    Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany

    3 shared publications
  • Sebastian Walther

    Department of Psychiatry, Psychosomatics and Psychotherapy, University of Würzburg, Würzburg, Germany

    3 shared publications
  • Stefan Fritze

    Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany

    3 shared publications

Latest Publications

  • Open Access

    Clinical and neurobiological correlates of tardive dyskinesia in schizophrenia spectrum disorders and mood disorders

    by Dilsa Cemre Akkoc Altinok, Sebastian Volkmer, Stefan Fritze, Geva A. Brandt, Lana Wölfl, Jacqueline Kukovic, Amanda Bellanti, Anastasia Pavlidou, Sofie von Känel, Stephanie Lefebvre, et al.

    Tardive dyskinesia (TD) is a persistent sensorimotor syndrome associated with antipsychotic exposure in schizophrenia spectrum disorders (SSD) and mood disorders (MOD), yet its neurobiological basis remains poorly understood. We investigated whether TD represents a distinct clinical and neurobiological phenotype across SSD and MOD. In this study, we examined a bicentric cohort of 453 individuals with SSD ( n = 360) or MOD ( n = 93), including early-psychosis (EP) and multiple-episode SSD patients. TD status was defined using Schooler and Kane criteria based on the Abnormal Involuntary Movement Scale (AIMS). Psychopathology was assessed with the Positive and Negative Syndrome Scale (PANSS). Structural MRI data were processed using FreeSurfer (v7.4.1). Propensity score matching was applied to compare TD-positive and TD-negative patients while controlling for age, sex, illness duration, antipsychotic dose, and PANSS scores. TD prevalence was 10.6% in multiple-episode SSD ( n = 31) and 7.5% in MOD ( n = 7), whereas no EP patients met criteria for TD. Logistic regression identified male sex ( p = 0.005) and higher PANSS general psychopathology scores ( p = 0.021) as independent predictors of TD. TD-positive patients showed reduced paracentral cortical surface area in both the matched SSD sample ( n = 86; p = 0.006, corr.) and the combined transdiagnostic sample ( n = 179; p = 0.024, corr.). These alterations were absent in EP patients. In conclusion, our findings suggest that TD is a transdiagnostic phenomenon, occurring in both SSD and MOD. However, TD in SSD appears to be associated with a distinct clinical and neurobiological phenotype, marked by greater illness severity, male predominance, and focal sensorimotor cortical alterations.

  • Open Access

    Replicable subcortical alterations linked to neurological soft signs in schizophrenia spectrum disorders – CORRIGENDUM

    by Amanda Bellanti, Sebastian Volkmer, Dilsa Cemre Akkoc Altinok, Stefan Fritze, Geva A. Brandt, Heike Tost, Urs Braun, Sofie von Känel, Anastasia Pavlidou, Stephanie Lefebvre, et al.

  • Open Access

    Replicable subcortical alterations linked to neurological soft signs in schizophrenia spectrum disorders

    by Amanda Bellanti, Seabastian Volkmer, Dilsa Cemre Akkoc Altinok, Stefan Fritze, Geva A. Brandt, Heike Tost, Urs Braun, Sofie von Känel, Anastasia Pavlidou, Stephanie Lefebvre, et al.

    Background: Neurological soft signs (NSS) are frequent in schizophrenia spectrum disorders (SSD) and have been linked to structural alterations in basal ganglia-thalamic (BGT) regions. We hypothesized that SSD patients would show BGT volume differences compared to healthy controls (HC) and that NSS severity would relate to BGT volume and surface morphology in a replicable pattern. Methods: Structural 3T T1-weighted MRI scans were obtained from 327 SSD patients and 134 matched HC in Mannheim (Germany) and Bern (Switzerland). NSS were assessed using the Heidelberg Scale and the Neurological Evaluation Scale (NES). BGT volumes were segmented using FSL-FIRST and compared across groups using general linear models adjusted for age, sex, intracranial volume, and daily antipsychotic medication. Associations with NSS scores were tested using regression analyses. Results: High-NSS compared to low-NSS SSD patients showed reduced left accumbens volume in both cohorts, with a significant main effect in the Mannheim cohort (β = −43.73, p = .002 uncorrected, p = .019 corrected) and a partial replication in the Bern cohort (β = −53.06, uncorrected p = .03, p > .05, corrected). In contrast, IF-related effects on left accumbens and bilateral thalamic volumes were cohort specific. Daily antipsychotic medication and illness duration did not mediate or moderate these associations. Conclusions: This bicentric MRI study provides converging evidence that NSS severity in SSD is associated with BGT alterations, particularly reduced left nucleus accumbens volume. However, thalamic and surface-level findings were cohort specific, indicating partial rather than uniform reproducibility. Associations were not explained by daily dosage of antipsychotic medication or illness duration.